Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Neofect Co. Ltd. (290660:KRX), powered by AI.
Neofect Co. Ltd. is currently trading at ₩1,010. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Neofect Co. Ltd. on Alpha Lenz.
Neofect Co. Ltd.'s P/E ratio is -44.3.
“Neofect Co. Ltd. trades at a P/E of -44.3 (undervalued) with modest ROE of -2.8%.”
Ask for details →Neofect Co. Ltd. is a specialized healthcare technology company focusing on the innovation and development of neuro-rehabilitation devices. Its primary function is to create advanced rehabilitation solutions aimed at improving the quality of life for patients recovering from neurological and musculoskeletal disorders. Neofect is renowned for its cutting-edge robotic and AI-driven products, such as robotic gloves and smart rehabilitation systems, which facilitate personalized and engaging therapy experiences. These technologies are particularly impactful in the healthcare sector, where they are utilized by hospitals, rehabilitation centers, and individual patients globally. The company plays a vital role in enhancing therapeutic outcomes, driven by its emphasis on making rehabilitation accessible and efficient. Founded in South Korea, Neofect has positioned itself as a significant player within the global medical technology market, continually expanding its product offerings to adapt to the increasing demands for innovative rehabilitation solutions.
“Neofect Co. Ltd. trades at a P/E of -44.3 (undervalued) with modest ROE of -2.8%.”
Ask for details →Neofect Co. Ltd. (ticker: 290660) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 57 employees. Market cap is $85.0B.
The current price is ₩1,010 with a P/E ratio of -44.26x and P/B of 1.08x.
ROE is -2.81% and operating margin is -11.43%. Annual revenue is $21.1B.